Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,711 | -10,871 | -13,123 | -11,239 | -10,101 |
| Depreciation Amortization | 117 | 135 | 125 | 131 | 169 |
| Accounts payable and accrued liabilities | -169 | -473 | -344 | 361 | -919 |
| Other Working Capital | -1,155 | -234 | -151 | -596 | -259 |
| Other Operating Activity | 328 | 748 | 673 | -20 | 1,696 |
| Operating Cash Flow | $-10,590 | $-10,695 | $-12,820 | $-11,363 | $-9,414 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19 | -60 | -22 | -250 | -178 |
| Purchase Of Investment | 0 | -25,140 | -30,352 | -29,757 | -51,395 |
| Sale Of Investment | 0 | 47,408 | 32,980 | 44,556 | 63,883 |
| Investing Cash Flow | $-19 | $22,208 | $2,606 | $14,549 | $12,310 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | 0 | N/A | N/A | -1,041 | N/A |
| Financing Cash Flow | $N/A | $N/A | $N/A | $-1,041 | $N/A |
| Beginning Cash Position | 24,387 | 12,874 | 23,088 | 20,943 | 18,047 |
| End Cash Position | 13,778 | 24,387 | 12,874 | 23,088 | 20,943 |
| Net Cash Flow | $-10,609 | $11,513 | $-10,214 | $2,145 | $2,896 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,590 | -10,695 | -12,820 | -11,363 | -9,414 |
| Capital Expenditure | -19 | -60 | -22 | -250 | -178 |
| Free Cash Flow | -10,609 | -10,755 | -12,842 | -11,613 | -9,592 |